Our data showed that administration with Gap26 during the subacute phase after cerebral ischemia deteriorated neurological deficits and downregulated dendritic spine density, indicating that Cx43 played an essential role in neurorehabilitation. The gene discussed is GJA1; the disease is Cerebral ischemia.